|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.840 USD | -10.70% |
|
+13.25% | +71.86% |
| 07-14 | Cumberland Pharmaceuticals Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
| 07-13 | Cumberland Pharmaceuticals Announces Special Dividend, Payable on July 31, 2026 | CI |
| Market Cap | 115M 100M 92.61M 85.31M 161M 11.05B 164M 1.11B 435M 5.41B 431M 422M 18.63B | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 114M 99.24M 91.59M 84.37M 159M 10.93B 163M 1.09B 430M 5.35B 426M 417M 18.43B | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.09% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cumberland Pharmaceuticals Inc.
| 1 day | -10.70% | ||
| 1 week | +13.25% | ||
| Current month | +5.56% | ||
| 1 month | +20.63% | ||
| 3 months | +121.36% | ||
| 6 months | +47.10% | ||
| Current year | +71.86% |
| 1 week | 5.84 |  | 8.09 |
| 1 month | 5.46 | | 8.09 |
| Current year | 2.69 | | 8.09 |
| 1 year | 1.85 | | 8.09 |
| 3 years | 1.04 | | 8.09 |
| 5 years | 1.04 | | 8.09 |
| 10 years | 0 | | 8.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 07/01/1999 |
John Hamm
DFI | Director of Finance/CFO | 70 | 17/05/2021 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 07/01/1999 |
| Director/Board Member | 74 | 10/09/2010 | |
James Jones
BRD | Director/Board Member | 78 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/18/26 A | Free | Executive/Senior Manager | 3,000 | 0.0201% | ||
| 3/18/26 A | Free | Director | 1,800 | 0.0120% | ||
| 3/18/26 A | Free | Responsable ventes & marketing | 3,000 | 0.0201% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.70% | +13.25% | +76.29% | +356.00% | 115M | |
| +0.85% | -3.11% | +49.29% | +162.34% | 1,043B | |
| +1.23% | -2.34% | +53.56% | +58.28% | 602B | |
| +0.04% | +1.83% | +33.53% | +87.11% | 449B | |
| +0.78% | -0.39% | +30.44% | +23.23% | 327B | |
| +1.41% | +0.56% | +31.41% | +47.13% | 279B | |
| -0.27% | -5.69% | +20.68% | +21.99% | 264B | |
| -1.42% | +0.73% | +22.50% | +61.06% | 201B | |
| -1.48% | -0.42% | +22.24% | +73.96% | 169B | |
| -0.36% | +3.30% | +1.79% | -31.03% | 143B | |
| Average | -1.15% | +2.07% | +34.17% | +86.01% | 347.72B | |
| Weighted average by Cap. | -0.04% | -1.81% | +37.79% | +83.51% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 37.87M 33.11M 30.56M 28.15M 53.08M 3.65B 54.25M 365M 143M 1.78B 142M 139M 6.15B | 44.52M 38.93M 35.93M 33.09M 62.41M 4.29B 63.78M 429M 169M 2.1B 167M 164M 7.23B |
| Net income | -6.48M -5.67M -5.23M -4.82M -9.08M -624M -9.28M -62.5M -24.55M -305M -24.33M -23.8M -1.05B | -2.84M -2.48M -2.29M -2.11M -3.98M -273M -4.06M -27.35M -10.74M -134M -10.65M -10.42M -460M |
| Net Debt | 2.61M 2.28M 2.1M 1.94M 3.66M 251M 3.74M 25.16M 9.88M 123M 9.79M 9.58M 423M | -1.26M -1.11M -1.02M -940K -1.77M -122M -1.81M -12.19M -4.79M -59.59M -4.75M -4.64M -205M |
Employees
93
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | $6.840 | -10.70% | 239,708 |
| 16/07/26 | $7.660 | -1.79% | 107,228 |
| 15/07/26 | $7.800 | +11.67% | 106,081 |
| 14/07/26 | $6.985 | +6.80% | 121,914 |
| 13/07/26 | $6.540 | +10.29% | 336,562 |
- Stock Market
- Stocks
- CPIX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
